Who is sponsoring NCT06938438?

NCT06938438 is sponsored by Tanta University.

What drugs are being tested in NCT06938438?

Interventions in NCT06938438: single locking miniplate, double conventional miniplates..

What condition does NCT06938438 study?

NCT06938438 studies Anterior Mandibular Fracture.

Is NCT06938438 still recruiting?

NCT06938438 is currently completed. Last updated 3 February 2026.

Last reviewed 2026-02-03 · How we verify

NCT06938438

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single Locking Miniplates Versus Double Non-Locking Miniplates in Anterior Mandibular Fracture

Completed NA Last updated 3 February 2026

What this trial tests

NA trial testing single locking miniplate in Anterior Mandibular Fracture in 20 participants. Completed in 20 September 2025.

Timeline

15 March 2022

Primary endpoint
1 December 2024

20 September 2025

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	15 March 2022
Primary completion	1 December 2024
Estimated completion	20 September 2025
Sites	1 location across Egypt

Drugs / interventions tested

single locking miniplate
double conventional miniplates.

Conditions studied

Anterior Mandibular Fracture — all drugs for Anterior Mandibular Fracture →

Sponsor

Tanta University

Who can join

Adults 17 to 40, any sex, with Anterior Mandibular Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare clinically and radiographically the using of single locking miniplate versus double non-locking miniplates in internal fixation of anterior mandibular fracture

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06938438 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 3 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06938438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing